Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection-Reference-Cited by-同舟云学术

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection

Published:2014-05-13 Issue:2 Volume:19 Page:256-262
ISSN:1569-9293
Container-title:Interactive CardioVascular and Thoracic Surgery
language:en
Short-container-title:Interact CardioVasc Thorac Surg

Author:

Marulli Giuseppe,Verderi Enrico,Zuin Andrea,Schiavon Marco,Battistella Lucia,Perissinotto Egle,Romanello Paola,Favaretto Adolfo Gino,Pasello Giulia,Rea Federico

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Link

http://academic.oup.com/icvts/article-pdf/19/2/256/2490240/ivu141.pdf

Reference25 articles.

1. Ginsberg RJ Vokes EE Raben A . Non-small cell lung cancer. In: De Vita VT Jr Hellman S Rosemberg SA , editors. Cancer: Principles and Practice. Philadelphia, PA: Lippincott-Raven; 1997. p. 858-911.

2. Ruckdeschel JC . Combined modality therapy of non-small cell lung cancer. Semin Oncol 1997;24:429-39.

3. Eberhardt WE Albain KS Pass H Putnam JB Gregor A Assamura H . Induction treatment before surgery for non-small cell lung cancer. Lung Cancer 2003;42:9-14.

4. Feld R Rubinstein LV Weisenberger TH . Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984;2:1352-8.

5. Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for Cure

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors of pathological complete response after induction (ypT0N0M0) in non-small cell lung cancer and short-term outcomes: Results of the Spanish Group of Video-assisted Thoracic Surgery (GE-VATS);Cirugía Española (English Edition);2022-06

2. LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT);Health Problems of Civilization;2022

3. PROSPECTS OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER AS A METHOD OF IMPROVING SURVIVAL;Wiadomości Lekarskie;2022

4. CORRELATION OF RELAPSE-FREE SURVIVAL WITH NEOADJUVANT TREATMENT IN PATIENTS WITH STAGE IIIA NON-SMALL CELL LUNG CANCER;Wiadomości Lekarskie;2022

5. Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?;Thoracic Cancer;2021-03-10